Snus use during the life-course and risk of the metabolic syndrome and its components

Abstract

Objective: We aimed to investigate the association between life-course exposure to snus and prevalence of the metabolic syndrome and its components in adulthood. Design and method: Tobacco habits at baseline (age 16) and three follow-ups (ages 21, 30 and 43) were assessed among 880 participants in a population-based cohort in Northern Sweden. Presence of the metabolic syndrome at age 43 was ascertained using the International Diabetes Federation criteria. Odds ratios and CIs for risk of the metabolic syndrome and its components by snus use at 16, 21, 30 and 43 years were calculated using logistic regression. Cumulative snus use was defined as number of life periods (1–4) with current snus use. Results: At age 43, 164 participants (18.6%) were current snus users. We found no association between exclusive snus use at the ages of 16, 21, 30 and 43 years and the metabolic syndrome at age 43 years. Snus use (among non-smokers) was associated with raised triglycerides and high blood pressure in crude analysis, but not in multivariable models. There was no association between cumulative snus use and risk of the metabolic syndrome. Cumulative snus use was associated with central obesity, raised triglycerides and impaired fasting glucose/diabetes mellitus type 2 in crude analyses, but not after adjustments. Conclusions: The health consequences of snus exposure from adolescence to mid-adulthood do not seem to include increased risk of the metabolic syndrome or its components. The cardio-metabolic risk of dual exposure to snus and cigarettes may warrant further attention.

Keywords

Swedish moist snuff snus smokeless tobacco metabolic syndrome metsy obesity hypertension triglycerides life-course

Get full access to this article

View all access options for this article.

References

SCB. Undersökningarna av levnadsförhållanden (ULF/SILC). Statistics Sweden, 2014.

Bolinder

[Use of snuff is a controversial public health issue]. Lakartidningen 2012;109:564–7.

Rodu

Godshall

WT.

Tobacco harm reduction: An alternative cessation strategy for inveterate smokers. Harm Reduction J 2006;3:37.

Ford

ES.

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care 2005;28:1769–78.

Alberti

Zimmet

Shaw

et al . The metabolic syndrome – a new worldwide definition. Lancet 2005;366:1059–62.

Nafziger

Lindvall

Norberg

et al . Who is maintaining weight in a middle-aged population in Sweden? A longitudinal analysis over 10 years. BMC Public Health 2007;7:108.

Norberg

Stenlund

Lindahl

et al . Contribution of Swedish moist snuff to the metabolic syndrome: A wolf in sheep’s clothing? Scand J Public Health 2006;34:576–83.

Janzon

Hedblad

Swedish snuff and incidence of cardiovascular disease. A population-based cohort study. BMC Cardiovasc Disord 2009;9:21.

Hergens

Ahlbom

Andersson

et al . Swedish moist snuff and myocardial infarction among men. Epidemiology 2005;16:12–16.

10.

Carlsson

Andersson

Araghi

et al . Smokeless tobacco (snus) is associated with an increased risk of type 2 diabetes: Results from five pooled cohorts. J Intern Med 2017.

11.

Hirsch

Hedner

Wernstedt

et al . Hemodynamic effects of the use of oral snuff. Clin Pharmacol Ther 1992;52:394–401.

12.

Hansson

Galanti

Hergens

et al . Snus (Swedish smokeless tobacco) use and risk of stroke: Pooled analyses of incidence and survival. J Intern Med 2014;276:87–95.

13.

Hansson

Galanti

Hergens

et al . Use of snus and acute myocardial infarction: Pooled analysis of eight prospective observational studies. Eur J Epidemiol 2012;27:771–9.

14.

Arefalk

Hambraeus

Lind

et al . Discontinuation of smokeless tobacco and mortality risk after myocardial infarction. Circulation 2014;130:325–32.

15.

Bolinder

Alfredsson

Englund

et al . Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 1994;84:399–404.

16.

Wändell

Bolinder

de Faire

et al . Association between metabolic effects and tobacco use in 60-year-old Swedish men. Eur J Epidemiol 2008;23:431–4.

17.

Lee

PN.

Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol 2011;59:197–214.

18.

Kuh

Ben-Shlomo

Lynch

et al . Life course epidemiology. J Epidemiol Community Health 2003;57:778–83.

19.

Gustafsson

Persson

Hammarstrom

Life course origins of the metabolic syndrome in middle-aged women and men: The role of socioeconomic status and metabolic risk factors in adolescence and early adulthood. Ann Epidemiol 2011;21:103–10.

20.

Gustafsson

Janlert

Theorell

et al . Socioeconomic status over the life course and allostatic load in adulthood: Results from the Northern Swedish Cohort. J Epidemiol Community Health 2011;65:986–92.

21.

Hammarstrom

Janlert

Cohort profile: The northern Swedish cohort. Int J Epidemiol 2012;41:1545–52.

22.

Unit. WHOCD. MONICA Manual: WHO MONICA Project. Geneva: World Health Organization, 1990.

23.

Wennberg

Eliasson

Hallmans

et al . The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J Intern Med 2007;262:360–7.

24.

Wennberg

Gustafsson

Dunstan

et al . Television viewing and low leisure-time physical activity in adolescence independently predict the metabolic syndrome in mid-adulthood. Diabetes Care 2013;36:2090–7.

25.

Rodu

Stegmayr

Nasic

et al . Evolving patterns of tobacco use in northern Sweden. J Intern Med 2003;253:660–5.

26.

Furberg

Lichtenstein

Pedersen

et al . Cigarettes and oral snuff use in Sweden: Prevalence and transitions. Addiction 2006;101:1509–15.

27.

Sundbeck

Grahn

Lonngren

et al . Snuff use associated with abdominal obesity in former smokers. Scand J Public Health 2009;37:487–93.

28.

Norberg

Malmberg

et al . Use of moist smokeless tobacco (snus) and the risk of development of alcohol dependence: A cohort study in a middle-aged population in Sweden. Drug Alcohol Depend 2015;149:151–7.

29.

Aubin

Farley

Lycett

et al . Weight gain in smokers after quitting cigarettes: Meta-analysis. BMJ 2012;345:e4439.

30.

Hallqvist

Lynch

Bartley

et al . Can we disentangle life course processes of accumulation, critical period and social mobility? An analysis of disadvantaged socio-economic positions and myocardial infarction in the Stockholm Heart Epidemiology Program. Soc Sci Med 2004;58:1555–62.